Gene editing startup Tome Biosciences to lay off almost all workers
Tome Biosciences, a high-profile gene editing startup, will terminate nearly its entire workforce during the first two weeks of November.
It disclosed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
